Javascript must be enabled to continue!
Activation induced decrease and recovery of TCR 2D affinity and bond lifetime
View through CrossRef
Abstract
Shortly after encountering antigen, T cells are considered transiently unresponsive or refractory to subsequent simulation. To determine whether antigen stimulation also changes the cell surface biophysical interaction between TCR and pMHC, we assessed the 2D TCR affinity and bond lifetime under force between this receptor ligand pair. Virus (LCMV) specific SMARTA transgenic CD4+ T cells were stimulated with peptide in vitro and 2D TCR affinity and bond lifetime determined at various time points after stimulation using the 2D micropipette adhesion frequency assay and the biomembrane force probe (BFP) respectively. We found activated T cells downregulated 2D affinity at twelve and twenty-four hours after seeing antigen with affinity recovering to naïve levels by forty-eight hours. Unlike pMHC tetramer staining which was dependent on TCR expression levels, the decrease in affinity was independent of antigen dose and degree of TCR downregulation. TCR:pMHC bond lifetime under force was also reduced early after antigen encounter with a steady recovery observed with time. Our data demonstrate a decrease in bond lifetime and relative 2D affinity of TCR and pMHC result from early T cell activation events followed by a recovery phase with both changes occurring independent of activation induced modulation of TCR expression. Thus, TCR affinity for pMHC is dynamic in the 2D T cell membrane context with cellular events allowing the T cell to fine-tune the ability of TCR to interact with antigen.
Oxford University Press (OUP)
Title: Activation induced decrease and recovery of TCR 2D affinity and bond lifetime
Description:
Abstract
Shortly after encountering antigen, T cells are considered transiently unresponsive or refractory to subsequent simulation.
To determine whether antigen stimulation also changes the cell surface biophysical interaction between TCR and pMHC, we assessed the 2D TCR affinity and bond lifetime under force between this receptor ligand pair.
Virus (LCMV) specific SMARTA transgenic CD4+ T cells were stimulated with peptide in vitro and 2D TCR affinity and bond lifetime determined at various time points after stimulation using the 2D micropipette adhesion frequency assay and the biomembrane force probe (BFP) respectively.
We found activated T cells downregulated 2D affinity at twelve and twenty-four hours after seeing antigen with affinity recovering to naïve levels by forty-eight hours.
Unlike pMHC tetramer staining which was dependent on TCR expression levels, the decrease in affinity was independent of antigen dose and degree of TCR downregulation.
TCR:pMHC bond lifetime under force was also reduced early after antigen encounter with a steady recovery observed with time.
Our data demonstrate a decrease in bond lifetime and relative 2D affinity of TCR and pMHC result from early T cell activation events followed by a recovery phase with both changes occurring independent of activation induced modulation of TCR expression.
Thus, TCR affinity for pMHC is dynamic in the 2D T cell membrane context with cellular events allowing the T cell to fine-tune the ability of TCR to interact with antigen.
Related Results
Modelling the T-cell repertoires of circulating T-cells and its application in cardiovascular diseases
Modelling the T-cell repertoires of circulating T-cells and its application in cardiovascular diseases
Modélisation du répertoire des lymphocytes T circulants et son application dans les maladies cardiovasculaires
Les maladies cardio-vasculaires MCV représentent la p...
Defining an allogeneic CAR-T approach by shRNA-mediated knockdown of the T-cell receptor.
Defining an allogeneic CAR-T approach by shRNA-mediated knockdown of the T-cell receptor.
e14551 Background: An allogeneic approach for CAR T-Cell therapy can significantly streamline manufacturing, provide more accessible options to patients as well as enhance safety ...
Multi-scale simulations of the T cell receptor reveal its lipid interactions, dynamics and the arrangement of its cytoplasmic region
Multi-scale simulations of the T cell receptor reveal its lipid interactions, dynamics and the arrangement of its cytoplasmic region
AbstractThe T cell antigen receptor (TCR-CD3) complex initiates T cell activation following recognition of peptides presented by Major Histocompatibility Complex (pMHC)-encoded pro...
Adoptive Transfer of CMV-Specific TCR-T Cells for the Treatment of CMV Infection after Haploidentical Hematopoietic Stem Cell Transplantation
Adoptive Transfer of CMV-Specific TCR-T Cells for the Treatment of CMV Infection after Haploidentical Hematopoietic Stem Cell Transplantation
Background: CMV reactivation after unmanipulated haploidentical stem cell transplantation (SCT) frequently occurs, causing life-threatening morbidities and transplantation failure....
T cell receptor α‐chain tail is required for protein kinase C‐mediated down‐regulation, but not for signaling
T cell receptor α‐chain tail is required for protein kinase C‐mediated down‐regulation, but not for signaling
AbstractAntigen stimulation through the T cell receptor (TCR) induces phosphorylation of the associated CD3 γδσ‐ and ζ‐chain cytoplasmic tails. These events lead to the induction o...
TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing
TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing
Abstract
ɑ/β T cells are key players in adaptive immunity. The specificity of T cells is determined by the sequences of the hypervariable T cell receptor (TCR) ɑ an...
Abstract 6667: Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors
Abstract 6667: Pan-cancer assessment of tumour and peripheral T-cell receptor repertoire dynamics in patients treated with immune checkpoint inhibitors
Abstract
Introduction: Clinical benefit from Immune Checkpoint Blockade (ICB) is a function of local T-cell specificity for tumor-associated antigens. However, overc...
Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
Adoptive transfer of CMV-specific TCR-T cells for the treatment of CMV infection after haploidentical hematopoietic stem cell transplantation
Background
Cytomegalovirus (CMV) reactivation after unmanipulated haploidentical stem cell transplantation (SCT) frequently occurs, causing life-threatening morbi...

